Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/30/2007WO2007096259A1 Hydantoin based kinase inhibitors
08/30/2007WO2007096251A1 Inhibitors of cpt in the central nervous system as antidiabetic and/or anti-obesity drugs
08/30/2007WO2007096193A2 Radiolabelled carbamates
08/30/2007WO2007096186A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
08/30/2007WO2007096174A1 Rapamycin derivatives for treating neuroblastoma
08/30/2007WO2007096173A1 Combinations of steroids and methylxanthine compounds
08/30/2007WO2007096170A1 Use of sodium channel blockers for the treatment of preterm labor
08/30/2007WO2007096151A2 Inhibitors of p38-kinase for treatment of pulmonary hypertension
08/30/2007WO2007096148A1 Immunoregulation
08/30/2007WO2007096088A1 Preparations effective against blemished skin and mild forms of acne with a content of hydroxymatairesinol as active principle
08/30/2007WO2007096078A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals
08/30/2007WO2007096072A2 New pyridin-3-amine derivatives
08/30/2007WO2007095977A1 Food product and process for preparing it
08/30/2007WO2007095949A2 Improved preparation of molecular imprinted polymers
08/30/2007WO2007095851A1 Unsaturated 5-member heterocycle compounds, uses and preparation methods theirof
08/30/2007WO2007095850A1 A pharmaceutical composition of docetaxel, preparation and use
08/30/2007WO2007095828A1 Dihydroporphine e6 zinc complexes as photosensitizer, their preparation and their use
08/30/2007WO2007095812A1 Substituted [1,3,5] triazine compounds, their processes for preparation and uses thereof
08/30/2007WO2007095789A1 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof
08/30/2007WO2007095784A1 The triazolyl-containing oxazolidinone derivatives, the preparation method and the uses thereof
08/30/2007WO2007095760A1 Cleavable carnitine compound
08/30/2007WO2007095756A1 Novel central-nervous system acting compounds and methods for the treatment of cns disorders
08/30/2007WO2007095753A1 2-(phenyl or heterocyclic) - 1h-phenanthro [9,10-d] imidazoles
08/30/2007WO2007095748A1 Cancerous disease modifying antibody 141205-05
08/30/2007WO2007095745A1 Cancerous disease modifying antibody 141205-02
08/30/2007WO2007095728A1 The use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron
08/30/2007WO2007095722A1 Doxorubicin formulations for anti-cancer use
08/30/2007WO2007095718A1 Nutritional composition and method for increasing creatine uptake and retention in skeletal muscle, increasing muscle mass and strength, increasing exercise capacity and for aiding recovery following exercise
08/30/2007WO2007095717A1 Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity
08/30/2007WO2007095696A1 Polyketide xanthones and uses thereof
08/30/2007WO2007095688A1 Methods for increasing the number of circulating cells
08/30/2007WO2007080324A3 Pyridopyrimidone derivatives, preparation thereof, therapeutic use thereof
08/30/2007WO2007079917A3 Combination of triazine derivatives and insulin sensitisers
08/30/2007WO2007079915A3 Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect
08/30/2007WO2007079260A9 Methods for improving the pharmacokinetics of hiv integrase inhibitors
08/30/2007WO2007079214A3 Prokineticin 2 receptor antagonists
08/30/2007WO2007079195A3 Gastric retentive gabapentin dosage forms and methods for using same
08/30/2007WO2007079177A9 Novel phytic citrate compounds and process for preparing the same
08/30/2007WO2007079169A3 Treatment for acute myeloid leukemia
08/30/2007WO2007079163A3 Prokineticin 1 receptor antagonists
08/30/2007WO2007079146A8 Treatment for non-hodgkin's lymphoma
08/30/2007WO2007077457A3 Treatment of equine laminitis with 5-ht1b/ 1d antagonists
08/30/2007WO2007077203A3 Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
08/30/2007WO2007076228A3 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
08/30/2007WO2007076055A9 Compositions and methods comprising proteinase activated receptor antagonists
08/30/2007WO2007075833A3 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
08/30/2007WO2007074477A3 Metaxalone polymorphs
08/30/2007WO2007074238A3 Novel n-alk-(e)-ylidene-n'-pyrimidin-2-yl hydrazine derivatives and use thereof as cytoprotective drugs
08/30/2007WO2007073303A3 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors
08/30/2007WO2007071632A3 2-pyridin-2-yl-quinazoline derivatives as potassium channel modulating agents for the treatment of respiratory diseases
08/30/2007WO2007071455B1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs
08/30/2007WO2007070556A3 N-(6-membered aromatic ring)-amido anti-viral compounds
08/30/2007WO2007064566A3 Heterocycle-substituted 3-alkyl azetidine derivatives
08/30/2007WO2007061829A3 Pharmaceutical composition
08/30/2007WO2007060618A3 Macrolides derivatives as antibacterial agents
08/30/2007WO2007060206A3 Further crystalline forms of rostafuroxin
08/30/2007WO2007058338A9 Oxazole compound and pharmaceutical composition
08/30/2007WO2007057767A3 Amino acid derivatives
08/30/2007WO2007057399A3 Treatment of cancer with indole derivatives
08/30/2007WO2007056388A9 Compositions and methods for modulating poly (adp-ribose) polymerase activity
08/30/2007WO2007054279A3 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions
08/30/2007WO2007053807A3 Calcitriol for treating intraocular diseases associated with angiogenesis
08/30/2007WO2007050726A3 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
08/30/2007WO2007050643A3 Compositions and their uses for gene therapy of bone conditions
08/30/2007WO2007045907A3 Ramipril formulation with increased stability
08/30/2007WO2007044639A3 Novel delivery of immune response modifiers for removal of chronic tattoos
08/30/2007WO2007044627A3 Compositions and methods for delivery of interfering rna
08/30/2007WO2007042912A3 Heterocyclic compounds as pstat3/il-6 inhibitors
08/30/2007WO2007041195A3 Macroheterocylic compounds as kinase inhibitors
08/30/2007WO2007041025A3 Radiolabeled glycine transporter inhibitors
08/30/2007WO2007036802A3 Sublingual dosage form comrising vitamin d analogue, in particular calcitriol
08/30/2007WO2007036792A3 Kit for parenteral administration of medicaments
08/30/2007WO2007034329A3 Compounds and methods for treatment of amyloid-beta-peptide related disorders
08/30/2007WO2007034326A3 Imidazole compounds for the treatment of neurological disorders
08/30/2007WO2007032794A3 Inhibition of viral gene expression using small interfering rna
08/30/2007WO2007020533A3 Process for the preparation of losartan potassium
08/30/2007WO2007019101A3 Hiv integrase inhibitors
08/30/2007WO2007008474A3 3 -ester prodrugs of estradiol
08/30/2007WO2007007208A3 Nonsteroidal immunomodulating kit and composition and uses thereof
08/30/2007WO2007000676A3 Guanosine-rich oligonucleotides as agents for inducing cell death in eukaryotic cells
08/30/2007WO2006127503A3 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
08/30/2007WO2006119211A3 Methods and compositions for treating ocular disorders
08/30/2007WO2006113837A3 Inhibitors of akt activity
08/30/2007WO2006078659A8 Stable prostaglandin-containing compositions
08/30/2007WO2006015854A3 Azetidine derivatives as ccr-3 receptor antagonists
08/30/2007WO2005062954A3 Modulation of hcn channels by second messengers
08/30/2007WO2000003682A3 Chemical composition having spermicidal, bactericidal and virucidal activity and apparatus for delivery into the vaginal canal
08/30/2007WO2000001393A8 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL
08/30/2007US20070203501 Spine distraction implant and method
08/30/2007US20070203497 Spine distraction implant and method
08/30/2007US20070203496 Spine distraction implant and method
08/30/2007US20070203495 Spine distraction implant and method
08/30/2007US20070203493 Spine distraction implant and method
08/30/2007US20070203490 Spine distraction implant and method
08/30/2007US20070203366 Perfluoropolyether derivative
08/30/2007US20070203357 Freeze-dried product of n-[o-(p-pivaloyloxy benzenesulfonylamino) benzoyl]glycine monosodium salt tetra-hydrate and a process for the manufacture thereof
08/30/2007US20070203353 Bipolar trans carotenoid salts and their uses
08/30/2007US20070203342 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine
08/30/2007US20070203339 Process for Preparation of Cyclic Prodrugs of PMEA and PMPA
08/30/2007US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
1 ... 3602 3603 3604 3605 3606 3607 3608 3609 3610 3611 3612 3613 3614 3615 3616 3617 3618 3619 3620 3621 3622 ... 7860